Flumazenil (also known as flumazepil code name Ro 15-1788) is a GABAA receptor antagonist primarily available by injection only and the only GABAA receptor antagonist on the market today.It was first introduced in 1987 by Hoffmann-La Roche under the trade name Anexate but only approved by the FDA on December 20 1991. Flumazenil went off patent in 2008 so at present generic formulations of this drug are available.
This page contains content from the copyrighted Wikipedia article "Flumazenil"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
